Outcome Assessment of Critical Care Pharmacist Services

Rudis M.I. , Brandl K.M. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med. 2000; 28(11): 3746–3750.

Brilli R.J. , Spevetz A. , Branson R.D. Critical care delivery in the intensive care unit: Defining clinical roles and the best practice model. Crit Care Med. 2001; 29(10): 2007–2019.

Haupt M.T. , Bekes C.E. , Brilli R.J. Guidelines on critical care services and personnel: Recommendations based on a system of categorization of three levels of care. Crit Care Med. 2003; 31(11): 2677–2683.

Maclaren R. , Devlin J.W. , Martin S.J. , Dasta J.F. , Rudis M.I. , Bond C.A. Critical care pharmacy services in United States hospitals. Ann Pharmacother. 2006; 40(4): 612–618.

Halpern N.A. , Pastores S.M. Critical care medicine in the United States 2000–2005: An analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med. 2010; 38(1): 65–71.

Dasta J.F. , Segal R. , Cunningham A. National survey of critical-care pharmaceutical services. Am J Hosp Pharm. 1989; 46(11): 2308–2312.

Chant C. , Dewhurst N.F. , Friedrich J.O. Do we need a pharmacist in the ICU? Intensive Care Med. 2015; 41(7): 1314–1320.

Erstad B.L. , Haas C.E. , O'Keeffe T. , Hokula C.A. , Parrinello K. , Theodorou A.A. Interdisciplinary patient care in the intensive care unit: Focus on the pharmacist. Pharmacotherapy. 2011; 31(2): 128–137.

Preslaski C.R. , Lat I. , MacLaren R. , Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013; 144(5): 1687–1695.

Kane S.L. , Weber R.J. , Dasta J.F. The impact of critical care pharmacists on enhancing patient outcomes. Intens Care Med. 2003; 29(5): 691–698.

Benedict N. , Hess M.M. History and future of critical care pharmacy practice. Am J Health Syst Pharm. 2015; 72(23): 2101–2105.

American College of Clinical Pharmacy, American Pharmacists Association, American Society of Health-System Pharmacists. A petition to the Board of Pharmacy Specialties Requesting recognition of critical care pharmacy practice as a specialty. 2012. http://www.accp.com/docs/positions/petitions/Final_CRITICAL_CARE_PETITION_For_BPS_Post.pdf. Accessed April 12, 2016.

Dellit T.H. , Owens R.C. , McGowan J.E. Jr .,. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44(2): 159–177.

Michalets E. , Creger J. , Shillinglaw W.R. Outcomes of expanded use of clinical pharmacist practitioners in addition to team-based care in a community health system intensive care unit. Am J Health Syst Pharm. 2015; 72(1): 47–53.

Tripathi S. , Crabtree H.M. , Fryer K.R. , Graner K.K. , Arteaga G.M. Impact of clinical pharmacist on the pediatric intensive care practice: An 11-year tertiary center experience. J Pediatr Pharmacol Ther. 2015; 20(4): 290–298.

Fideles G.M. , de Alcantara-Neto J.M. , Peixoto Junior A.A. Pharmacist recommendations in an intensive care unit: Three-year clinical activities. Rev Bras Ter Intensiva. 2015; 27(2): 149–154.

Society of Critical Care Medicine. About SCCM: Strategic plan. http://www.sccm.org/About-SCCM/Pages/Governance.aspx. Accessed April 13, 2016.

Baggs J.G. , Schmitt M.H. , Mushlin A.I. Association between nurse-physician collaboration and patient outcomes in three intensive care units. Crit Care Med. 1999; 27(9): 1991–1998.

Dimick J.B. , Pronovost P.J. , Heitmiller R.F. , Lipsett P.A. Intensive care unit physician staffing is associated with decreased length of stay, hospital cost, and complications after esophageal resection. Crit Care Med. 2001; 29(4): 753–758.

Johnson V. , Mangram A. , Mitchell C. , Lorenzo M. , Howard D. , Dunn E. Is there a benefit to multidisciplinary rounds in an open trauma intensive care unit regarding ventilator-associated pneumonia? Am Surg. 2009; 75(12): 1171–1174.

Pronovost P. , Berenholtz S. , Dorman T. , Lipsett P.A. , Simmonds T. , Haraden C. Improving communication in the ICU using daily goals. J Crit Care. 2003; 18(2): 71–75.

Stone M.E. Jr ., Snetman D. , ON A Daily multidisciplinary rounds to implement the ventilator bundle decreases ventilator-associated pneumonia in trauma patients: but does it affect outcome? Surg Infect (Larchmt). 2011; 12(5): 373–378.

Donchin Y. , Gopher D. , Olin M. A look into the nature and causes of human errors in the intensive care unit. Crit Care Med. 1995; 23(2): 294–300.

Pronovost P.J. , Thompson D.A. , Holzmueller C.G. Toward learning from patient safety reporting systems. J Crit Care. 2006; 21(4): 305–315.

Beardsley J.R. , Jones C.M. , Williamson J. , Chou J. , Currie-Coyoy M. , Jackson T. Pharmacist involvement in a multidisciplinary initiative to reduce sepsis-related mortality. Am J Health Syst Pharm. 2016; 73(3): 143–149.

Jiang S.P. , Chen J. , Zhang X.G. , Lu X.Y. , Zhao Q.W. Implementation of pharmacists' interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital. Ther Clin Risk Manag. 2014; 10: 861–866.

Shulman R. , McKenzie C.A. , Landa J. Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK). J Crit Care. 2015; 30(4): 808–813.

Leape L.L. , Cullen D.J. , Clapp M.D. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282(3): 267–270.

MacLaren R. , Bond C.A. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009; 29(7): 761–768.

MacLaren R. , Bond C.A. , Martin S.J. , Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008; 36(12): 3184–3189.

Montazeri M. , Cook D.J. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med. 1994; 22(6): 1044–1048.

Kopp B.J. , Mrsan M. , Erstad B.L. , Duby J.J. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007; 64(23): 2483–2487.

MacLaren R. , Brett McQueen R. , Campbell J. Clinical and financial impact of pharmacy services in the intensive care unit: Pharmacist and prescriber perceptions. Pharmacotherapy. 2013; 33(4): 401–410.

Benedict N. , Felbinger M. , Ridenour T. , Anthes A. , Altawalbeh S. , Kane-Gill S. Correlation of patient-reported outcomes of sedation and sedation assessment scores in critically ill patients. J Crit Care. 2014; 29(6): 1132 e1135–1139.

Weant K.A. , Armitstead J.A. , Ladha A.M. , Sasaki-Adams D. , Hadar E.J. , Ewend M.G. Cost effectiveness of a clinical pharmacist on a neurosurgical team. Neurosurgery. 2009; 65(5): 946–950; discussion 950–941.

Sutherland S.M. , Chawla L.S. , Kane-Gill S.L. Utilizing electronic health records to predict acute kidney injury risk and outcomes: Workgroup statements from the 15(th) ADQI Consensus Conference. Can J Kidney Health Dis. 2016; 3: 11.

Liput S.A. , Kane-Gill S.L. , Seybert A.L. , Smithburger P.L. A review of the perceptions of healthcare providers and family members toward family involvement in active adult patient care in the ICU. Crit Care Med. 2016; 44: 1191–1197.

Benjamin J.M. , Cox E.D. , Trapskin P.J. Family-initiated dialogue about medications during family-centered rounds. Pediatrics. 2015; 135(1): 94–101.

Kaboli P.J. , Glasgow J.M. , Jaipaul C.K. Identifying medication misadventures: Poor agreement among medical record, physician, nurse, and patient reports. Pharmacotherapy. 2010; 30(5): 529–538.

van den Bemt P.M. , Egberts A.C. , Lenderink A.W. Adverse drug events in hospitalized patients. A comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol. 1999; 55(2): 155–158.

Smithburger P.L. , Alexander S.A. , Gries C.J. , Korenoski A.S. , Kane-Gill S.L. Provider and family perceptions of family involvement in delirium prevention in an ICU [abstract]. Crit Care Med. 2015; 43(12 suppl): 139.

Society of Critical Care Medicine. THRIVE. http://www.sccm.org/research/quality/thrive/Pages/default.aspx. Accessed April 13, 2016.

Buckley M.S. , Park A.S. , Anderson C.S. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. Am J Med. 2015; 128(8): 905–913.

Flurie R.W. , Gonzales J.P. , Tata A.L. , Millstein L.S. , Gulati M. Hospital delirium treatment: Continuation of antipsychotic therapy from the intensive care unit to discharge. Am J Health Syst Pharm. 2015; 72(23 suppl 3): S133–139.

Shin S. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: A retrospective chart review. Ther Clin Risk Manag. 2015; 11: 649–657.

US Department of Health and Human Services; Office of Disease Prevention and Health Promotion. National action plan for adverse drug event prevention. 2014. http://health.gov/hcq/pdfs/ade-action-plan-508c.pdf. Accessed April 13, 2016.

Stollings J.L. , Caylor M.M. Postintensive care syndrome and the role of a follow-up clinic. Am J Health Syst Pharm. 2015; 72(15): 1315–1323.

Kane-Gill S.L. Transforming the medication regimen review process of high-risk drugs using a patient-centered telemedicine-based approach to prevent adverse drug events in the nursing home. Agency for Healthcare Research and Quality. 1R18HS024208-01. 2015. https://projectreporter.nih.gov/project_info_description.cfm?aid=8996873&icde=30102484&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC

Stollings JL , Foss JJ , Ely EW Pharmacist leadership in ICU quality improvement: Coordinating spontaneous awakening and breathing trials. Ann Pharmacother. 2015; 49(8): 883–891.

Forni A. , Skehan N. , Hartman C.A. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients. Ann Pharmacother. 2010; 44(3): 432–438.

Marshall J. , Finn C.A. , Theodore A.C. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008; 36(2): 427–433.

Welch S.C. , Bauer S.R. Initial care for patients with severe sepsis and septic shock: The next ICU quality measure. Hosp Pharm. 2016; 51(1): 19–25.

Schramm G.E. , Kashyap R. , Mullon J.J. , Gajic O. , Afessa B. Septic shock: A multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality. Crit Care Med. 2011; 39(2): 252–258.

Ng T.M. , Bell A.M. , Hong C. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: A pilot study. Ann Pharmacother. 2008; 42(4): 475–482.

Russell J.M. , Nick-Dart R.L. , Nornhold B.D. Development of a pharmacist-driven protocol for automatic medication dosage adjustments in obese patients. Am J Health Syst Pharm. 2015; 72(19): 1656–1663.

Jiang S.P. , Xu Y.Y. , Ping Y. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment. Eur J Intern Med. 2014; 25(10): 930–935.

Roberts J.A. , Abdul-Aziz M.H. , Lipman J. Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions. Lancet Infect Dis. 2014; 14(6): 498–509.

Bourne R.S. , Whiting P. , Brown L.S. , Borthwick M. Pharmacist independent prescribing in critical care: Results of a national questionnaire to establish the 2014 UK position. Int J Pharm Pract. 2016; 24(2): 104–113.

Heck T. , Gunther M. , Bresee L. , Mysak T. , McMillan C. , Koshman S. Independent prescribing by hospital pharmacists: Patterns and practices in a Canadian province. Am J Health Syst Pharm. 2015; 72(24): 2166–2175.

Manias E. , Williams A. , Liew D. Interventions to reduce medication errors in adult intensive care: A systematic review. Br J Clin Pharmacol. 2012; 74(3): 411–423.

Wang T. , Benedict N. , Olsen K.M. Effect of critical care pharmacist's intervention on medication errors: A systematic review and meta-analysis of observational studies. J Crit Care. 2015; 30(5): 1101–1106.

Lee A.J. , Chiao T.B. , Lam J.T. , Khan S. , Boro M.S. Improving medication safety in the ICU: The pharmacist's role. Hosp Pharm. 2007; 42(4): 337–344.

Claus B.O. , Robays H. , Decruyenaere J. , Annemans L. Expected net benefit of clinical pharmacy in intensive care medicine: A randomized interventional comparative trial with matched before-and-after groups. J Eval Clin Pract. 2014; 20(6): 1172–1179.